Performance of a PLK1-based immune risk model for prognosis and treatment response prediction in breast cancer.

Yan Chen,Yiqing You,Qiaoling Wu,Jing Wu,Shujing Lin,Yang Sun,Zhaolei Cui

Cancer medicine（2023）

引用 0|浏览22

暂无评分

摘要

This PLK1-based immune risk model can effectively predict the prognosis and tumor progression of BRCA, identify gene mutations, and evaluate patient's response toward immunotherapy and chemotherapy regimens.

查看译文

关键词

breast cancer (BRCA),immune infiltration,polo-like kinase 1 (PLK1),prognosis,risk model

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要